Axial spondyloarthritis: A new disease entity, not necessarily early ankylosing spondylitis


Autoria(s): Robinson, P. C.; Wordsworth, B. P.; Reveille, J. D.; Brown, Matthew A.
Data(s)

01/02/2013

Resumo

New classification criteria for axial spondyloarthritis have been developed with the goal of increasing sensitivity of criteria for early inflammatory spondyloarthritis. However these criteria substantially increase heterogeneity of the resulting disease group, reducing their value in both research and clinical settings. Further research to establish criteria based on better knowledge of the natural history of non-radiographic axial spondyloarthritis, its aetiopathogenesis and response to treatment is required. In the meantime the modified New York criteria for ankylosing spondylitis remain a very useful classification criteria set, defining a relatively homogenous group of cases for clinical use and research studies.

Identificador

http://eprints.qut.edu.au/87746/

Publicador

BMJ Publishing Group

Relação

DOI:10.1136/annrheumdis-2012-202073

Robinson, P. C., Wordsworth, B. P., Reveille, J. D., & Brown, Matthew A. (2013) Axial spondyloarthritis: A new disease entity, not necessarily early ankylosing spondylitis. Annals of the Rheumatic Diseases, 72(2), pp. 162-164.

Fonte

School of Biomedical Sciences; Institute of Health and Biomedical Innovation

Palavras-Chave #adalimumab #HLA B27 antigen #ankylosing spondylitis #axial spondyloarthritis #clinical feature #diagnostic accuracy #diagnostic error #differential diagnosis #disease classification #drug response #human #nuclear magnetic resonance imaging #priority journal #reactive arthritis #review #sacroiliitis #sensitivity analysis #sensitivity and specificity #sex ratio #spondylarthritis #Humans #Spondylitis #Ankylosing
Tipo

Journal Article